Eurobio Scientific SA banner

Eurobio Scientific SA
F:E8TN

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
F:E8TN
Watchlist
Price: 20.1 EUR Market Closed
Market Cap: €201.9m

Wall St Price Targets

E8TN Price Targets Summary
Eurobio Scientific SA

Wall Street analysts forecast E8TN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for E8TN is 37.17 EUR with a low forecast of 36.8 EUR and a high forecast of 38.26 EUR.

Lowest Forecast
Price Target
36.8 EUR
83% Upside
Average Forecast
Price Target
37.17 EUR
85% Upside
Highest Forecast
Price Target
38.26 EUR
90% Upside
Eurobio Scientific SA Competitors:
Price Targets
EOLS
Evolus Inc
71% Upside
ZEAL
Zealand Pharma A/S
39% Upside
TTD
Trade Desk Inc
4% Upside
SUPN
Supernus Pharmaceuticals Inc
45% Upside
AREC
American Resources Corp
152% Upside
WINA
Winmark Corp
73% Upside
ENVX
Enovix Corp
246% Upside

Revenue
Forecast

29% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
29% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 1 year is 7%.

Gross Profit
Forecast

N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

The compound annual growth rate for Gross Profit over the next 1 year is 14%.

Operating Income
Forecast

N/A
Past Growth
173% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
N/A
Past Growth
173% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

The compound annual growth rate for Operating Income over the next 1 year is 173%.

Pre-Tax Income
Forecast

N/A
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 5 years is 55%.

Net Income
Forecast

N/A
Past Growth
146% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
N/A
Past Growth
146% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

The compound annual growth rate for Net Income over the next 1 year is 146%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is E8TN's stock price target?
Price Target
37.17 EUR

According to Wall Street analysts, the average 1-year price target for E8TN is 37.17 EUR with a low forecast of 36.8 EUR and a high forecast of 38.26 EUR.

What is the Revenue forecast for Eurobio Scientific SA?
Projected CAGR
7%

Over the last 14 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 1 year is 7%.

What is the Gross Profit forecast for Eurobio Scientific SA?
Projected CAGR
14%

The compound annual growth rate for Gross Profit over the next 1 year is 14%.

What is the Operating Income forecast for Eurobio Scientific SA?
Projected CAGR
173%

The compound annual growth rate for Operating Income over the next 1 year is 173%.

What is the Pre-Tax Income forecast for Eurobio Scientific SA?
Projected CAGR
55%

The compound annual growth rate for Pre-Tax Income over the next 5 years is 55%.

What is the Net Income forecast for Eurobio Scientific SA?
Projected CAGR
146%

The compound annual growth rate for Net Income over the next 1 year is 146%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett